Drugs at age 17 - Trends, use context and risk-ranking
Tendances n° 49, OFDT, 4 p.
The 2005 ESCAPAD survey (Survey on Health and Consumption on Call-up and Preparation for Defence Day) is the fifth nationwide survey of its kind to be organised. The survey completes the device introduced by OFTD in order to monitor usage throughout the adult population (the Baromètre Santé or "Health Barometer" organised under the scientific supervision of the Inpes), and the ESPAD project organised among the school-age population (the European School Survey Project on Alcohol and other Drugs, in collaboration with the Inserm). It covers mainland France but also the overseas départements and local authorities, using the same methodology for each. The data from the 2005 survey was drawn from the replies of 29,393 young people in mainland France aged 17 years old at the time the survey was carried out. It makes it possible to describe trends over five years but also includes new questions concerning the context of alcohol and cannabis use, the driving of a motor vehicle under the influence and accidents related to the consumption of these products. Finally, thanks to the introduction of a new question, cannabis sourcing methods can now also be identified and recorded.
François Beck, Stéphane Legleye, Stanislas Spilka
Download the PDF file (129 Ko)
Drugs in Europe
- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe
Country situation summaries
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.